Millennium Pharmaceuticals News

CAMBRIDGE, Mass. -- -- Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that 101 abstracts featuring the Company's oncology molecules have been accepted at the annual meeting of the American Society of Clinical Oncology being held in Chicago, Illinois, June 1-5, 2012.

BOTHELL, Wash. -- -- Seattle Genetics, Inc. today reported financial results for the first quarter ended March 31, 2012.

Millennium: The Takeda Oncology Company, of Cambridge and Seattle Genetics Inc. of Bothell, Wash., said today that they have started a Phase 3 clinical trial to evaluate Adcetris, a drug candidate they are jointly developing for patients with CD30-expressing relapsed cutaneous T-cell lymphoma.

Doubling cigarette prices could help reduce tobacco use Duchess of Cambridge enjoys secret nights out with Prince of Wales Assam: Mahanta locks AGP top job 'Self-repair' mechanism may help identify and fix head and facial defects Spying case: Diplomat allowed to visit heritage sites How probiotic bacteria prevent inflammatory bowel disorders FA to ... (more)

Mumbai : Takeda Pharmaceutical Co Ltd, Japan's largest drug firm, will acquire US biopharma firm Millennium Pharmaceuticals Inc for $8.8 billion, in the biggest overseas acquisition by a Japanese drugmaker.